Table 1.
Demographic, baseline clinical characteristics, and peri- and postoperative courses in patients with ineffective esophageal motility who underwent laparoscopic anti-reflux surgery with the RefluxStop implant
| Parameter | n = 20 |
|---|---|
| Demographics | |
| Sex (female) | 10 (50%) |
| Age (years), mean (SD) | 57.4 (12.6) |
| BMI (kg/m2), mean (SD) | 26.5 (4.8) |
| ASA classification (1–6), median (IQR) | 2 (2–3) |
| Reflux-related clinical parameters | |
| Axial length of hernia (cm), median (IQR) | 4.5 (3.75–5) |
| Preoperative dysphagia | 12 (60%) |
| Preoperative Barrett’s esophagus | 6 (30%) |
| Preoperative reflux esophagitis grade C or D | 4 (20%) |
| PPI use before surgery | 20 (100%) |
| PPI use 12 months after surgery | 4 (20%) |
| Perioperative characteristics | |
| Abdominal access | |
| Laparoscopic | 19 (95%) |
| Conversion to open | 1 (5%) |
| Reinforcement with Phasix-ST® mesh | 2 (10%) |
| Duration of operation (min), median (IQR) | 59.5 (50.25–64) |
| Intraoperative complication | 1 (5%) |
| Duration of hospital stay (days), median (IQR) | 3.5 (3–4) |
| Postoperative characteristics | |
| Complications ≥ grade II within 90 days* | 3 (15%) |
| Dysphagia requiring dilatation | 3 (15%) |
| Reoperation within 12 months | 1 (5%) |
| Recurrence of reflux within 12 months | 1 (5%) |
| Migration of the implant within 12 months | 1 (5%) |
Values are n (%) unless stated otherwise. BMI, body mass index. ASA, American Society of Anesthesiologists. PPI, proton pump inhibitors
*Postoperative complications are graded according to the Clavien–Dindo classification system